CBIO vs NIO · rev $1.0M vs rev $12.51B
Crescent Biopharma, Inc. (CBIO) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
CBIO currently screens at market cap $491.3M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the CBIO and NIO stock pages for the full models.
Not investment advice.